TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Tempest Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.60−0.02 (-3.86%)
Close on Oct 19, 2026
- Market cap
- $9.14M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 13, 2025(first seen in filings) | 1-for-13 reverse | Earlier per-share figures multiplied by 13 |
| Apr 9, 2025 | 1-for-13 reverse | Earlier per-share figures multiplied by 13 |
| Jun 28, 2021 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Apr 1, 2019(first seen in filings) | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Dec 10, 2018 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |